首頁 > 市場調查報告書 > 製藥

生物製劑基因治療學和RNAi 分子標靶治療學核酸藥物

市場調查報告書

商品編碼

2052711

適體市場：按類型、應用程式、最終用戶和地區分類

Aptamers Market, By Type, By Application, By End User, By Geography

出版日期: 2026年04月01日 | 出版商:

Coherent Market Insights | 英文 170 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計到2026年，適體市場規模將達到101.7億美元，2033年將達到327.7億美元。預計從2026年到2033年，其複合年成長率將達到18.2%。

報告範圍		報告詳情
基準年：	2025	2026年市場規模：	101.7億美元
歷史數據時期：	2020年至2024年	預測期：	2026年至2033年
2026年至2033年預測期間的複合年成長率：	18.20%	2033年市場規模預測：	327.7億美元

適體是能夠與特定標靶分子結合的單鏈去氧核糖核酸（DNA）或核糖核酸（RNA）分子。它們可以透過化學合成，並以高親和性和特異性識別和結合蛋白質、小分子或細胞表面標靶。與抗體相比，適體具有許多優勢，包括體積小、易於生產和修飾、無免疫抗原性以及優異的組織穿透性。它們被廣泛應用於科研、診斷和治療等領域。

市場動態：

全球適體市場的成長主要得益於生命科學和製藥業研發投入的不斷增加。此外，由於適體具有許多優勢，其在診斷和研究中作為抗體替代品的應用日益廣泛，也推動了市場成長。然而，適體研發和生產的高成本仍是限制市場成長的主要障礙。而能夠簡化生產流程、降低成本的新型適體生產技術的出現，則為市場相關人員帶來了巨大的機會。

本研究的主要特點：

本研究確定了各個細分市場的潛在商機，並說明了該市場具有吸引力的投資提案矩陣。
此外，本研究還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域展望以及主要參與者採取的競爭策略的重要見解。
本研究根據以下參數對全球適體市場的主要參與者進行了分析：公司亮點、產品系列、主要特徵、財務表現和策略。
透過利用本報告中的見解，企業行銷負責人和經營團隊將能夠就未來的產品發布、產品升級、市場擴張和行銷策略做出明智的決策。
全球適體市場的目標客戶群包括產業內的各類相關人員，例如投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
透過各種用於分析全球適體市場的策略矩陣，相關人員將能夠更輕鬆地做出決策。

北美洲
- 美國
- 加拿大
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 其他拉丁美洲國家
歐洲
- 英國
- 德國
- 義大利
- 法國
- 西班牙
- 俄羅斯
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- ASEAN
- 澳洲
- 韓國
- 其他亞太國家
中東
- GCC
- 以色列
- 其他中東國家
非洲
- 北非
- 中非
- 南非

第8章競爭情勢

公司簡介
- AstraZeneca
- Achiko AG
- Agilent Technologies, Inc.
- Amsbio
- Aptagen LLC
- Aptamer Group
- CAGE Bio Inc.
- GC Biopharma Corp.
- GlyTech, Inc.
- IVERIC bio, Inc.
- NeoNeuro SAS
- Novartis AG
- Ophthotech Corporation
- SomaLogic Operating Co., Inc.
- TAGCyx Biotechnologies Inc.
- Vivonics Inc.
- Zentek Ltd.

第9章分析師建議

機會分析
分析師意見
Coherent Opportunity Map

第10章參考文獻與調查方法

參考
調查方法

簡介目錄

Product Code: CMI774

Aptamers Market is estimated to be valued at USD 10.17 Bn in 2026 and is expected to reach USD 32.77 Bn by 2033, growing at a compound annual growth rate (CAGR) of 18.2% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 10.17 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	18.20%	2033 Value Projection:	USD 32.77 Bn

Aptamers are single stranded Deoxyribonucleic acid (DNA) or Ribonucleic acid (RNA) molecules that bind to a specific target molecule. These can be chemically synthesized to recognize and bind protein, small molecule or cell surface targets with high affinity and specificity. Aptamers have several advantages over antibodies such as small size, easy production and modification, lack of immunogenicity and better tissue penetration. These have wide applications in research, diagnostics, therapeutics and others.

Market Dynamics:

Global aptamers market growth is driven by rising research and development investments in life sciences and pharmaceutical industries. Growing use of aptamers as an alternative to antibodies in diagnostics and research due to their advantages is also boosting the market growth. However, high costs associated with aptamer development and production is a major factor hampering the market growth. Emergence of novel technologies for simpler and cost-effective production of aptamers provides a significant opportunity for market players.

Key Features of the Study:

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global aptamers market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
Key companies covered as a part of this study AstraZeneca, Achiko AG, Agilent Technologies, Inc., Amsbio, Aptagen LLC, Aptamer Group, CAGE Bio Inc., GC Biopharma Corp., GlyTech, Inc., IVERIC bio, Inc., NeoNeuro SAS, Novartis AG, Ophthotech Corporation, SomaLogic Operating Co., Inc., TAGCyx Biotechnologies Inc., Vivonics Inc., Zentek Ltd.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
Global aptamers market caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global aptamers market.

Market Segmentation-

By Type (Revenue, USD Bn, 2021 - 2033)
Nucleic Acid
- DNA-based Aptamers
- RNA-based Aptamers
- XNA-based Aptamers
Peptide Aptamers
By Application (Revenue, USD Bn, 2021 - 2033)
Diagnostics
Therapeutics
Research and Development
By End User (Revenue, USD Bn, 2021 - 2033)
Biotechnology and Pharmaceutical Companies
Academic and Research Institutions
Contract Research Organization

Regional Insights (Revenue, USD Bn, 2021 - 2033)

North America
- U.S.
- Canada
Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
Middle East
- GCC Countries
- Israel
- Rest of Middle East
Africa
- South Africa
- North Africa
- Central Africa
Company Profiles:
AstraZeneca
Achiko AG
Agilent Technologies, Inc.
Amsbio
Aptagen LLC,
Aptamer Sciences, Inc.
CAGE Bio Inc.
GC Biopharma Corp.
GlyTech, Inc.
IVERIC bio, Inc.
NeoNeuro SAS
Novartis AG
Ophthotech Corporation
SomaLogic Operating Co., Inc.
TAGCyx Biotechnologies Inc.
Vivonics Inc.
Zentek Ltd.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Type
- Market Snapshot, By Application
- Market Snapshot, By End User
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Opportunities
Impact Analysis
Market Trends
Key Developments
Regulatory Scenario
Manufacturer Revenue
Acquisitions and Partnerships Scenario
Product Launches/Approvals
Funding and Investments
PEST Analysis
Porter's Analysis

4. Global Aptamers Market, By Type, 2021 - 2033, (USD Bn)

Overview
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Nucleic Acid
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  - DNA-based Aptamers
  - RNA-based Aptamers
  - XNA-based Aptamers
Peptide Aptamers
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

5. Global Aptamers Market, By Application, 2021 - 2033, (USD Bn)

Overview
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Diagnostics
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Therapeutics
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Research and Development
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

6. Global Aptamers Market, By End User, 2021 - 2033, (USD Bn)

Overview
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Biotechnology and Pharmaceutical Companies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Academic and Research Institutions
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Contract Research Organization
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

7. Global Aptamers Market, By Region, 2021 - 2033, (USD Bn)

Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Region, 2021-2033
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
  - GCC
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 - 2033, (USD Bn)
  - North Africa
  - Central Africa
  - South Africa

8. Competitive Landscape

Company Profiles
- AstraZeneca
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Achiko AG
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Agilent Technologies, Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Amsbio
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Aptagen LLC
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Aptamer Group
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- CAGE Bio Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- GC Biopharma Corp.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- GlyTech, Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- IVERIC bio, Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- NeoNeuro SAS
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Novartis AG
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Ophthotech Corporation
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- SomaLogic Operating Co., Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- TAGCyx Biotechnologies Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Vivonics Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Zentek Ltd.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies